# NINLARO Capsules Drug Use-Results Survey (All-Case Surveillance) "Relapsed/Refractory Multiple Myeloma"

> **NCT03169361** · — · COMPLETED · sponsor: **Takeda** · enrollment: 774 (actual)

## Conditions studied

- Relapsed/Refractory Multiple Myeloma

## Interventions

- **DRUG:** Ixazomib

## Key facts

- **NCT ID:** NCT03169361
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-05-24
- **Primary completion:** 2022-03-08
- **Final completion:** 2022-03-08
- **Target enrollment:** 774 (ACTUAL)
- **Last updated:** 2023-12-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03169361

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03169361, "NINLARO Capsules Drug Use-Results Survey (All-Case Surveillance) "Relapsed/Refractory Multiple Myeloma"". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03169361. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*